A role for Toll-like receptor mediated signals in neutrophils in the pathogenesis of the anti-phospholipid syndrome. by Gerd Gladigau, Philipp Haselmayer, Inge Scharrer, Markus Munder, Nadine Prinz, Karl Lackner, Hansjörg Schild, Pamela Stein, Markus P Radsak

Get full text

Identification of pharmacodynamic biomarker hypotheses through literature analysis with IBM Watson. by Sonja Hatz, Scott Spangler, Andrew Bender, Matthew Studham, Philipp Haselmayer, Alix M B Lacoste, Van C Willis, Richard L Martin, Harsha Gurulingappa, Ulrich Betz

Get full text

Identifying lupus Patient Subsets Through Immune Cell Deconvolution of Gene Expression Data in Two Atacicept Phase II Studies by Matthew Studham, Cristina Vazquez‐Mateo, Eileen Samy, Philipp Haselmayer, Aida Aydemir, P. Alexander Rolfe, Joan T. Merrill, Eric F. Morand, Julie DeMartino, Amy Kao, Robert Townsend

Get full text

EVOBRUTINIB TREATMENT REDUCES THE DAMAGE TO THE CNS AND INCREASES THE NUMBER OF CLASSICAL DENDRITIC CELLS IN EXPERIMENTAL MULTIPLE SCLEROSIS by Mari Paz Serrano-Regal, Leticia Calahorra, Inmaculada Alonso-García, Ursula Boschert, Philipp Haselmayer, María Cristina Ortega, Isabel Machin-Diaz, Celia Camacho-Toledano, Jennifer García-Arocha, Diego Clemente

Get full text